TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ARWR

Arrowhead Pharmaceuticals Inc

Healthcare · Biotechnology

65.90$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Arrowhead Pharmaceuticals Inc (ARWR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 180 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARWR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-35 -66 -64 -24 -47 173 -96 171 -136 -154 -463 180
1.3 2.3 3.3 4.7 4.7 4.4 5.9 8.3 10 12 19 24
5.7 10 12 7.9 8.5 12 43 77 121 78 74 63
14 19 8.1 7.0 8.0 13 43 77 125 90 – –
5.0 3.4 5.7 -1.2 -5.9 87 -61 229 -98 -52 25 -18
1.7 2.0 3.9 7.9 1.4 12 12 24 53 177 141 23
-36 14 13 -49 -7.4 -48 -241 -142 -5.4 -96 -420 -129
0.0 0.0 0.0 0.0 0.0 – – – – – – –
186 0.5 -0.6 -0.4 -0.1 69 258 11 5.2 – – –
-0.2 -0.2 -0.2 -0.2 -0.2 -2.4 250 250 250 250 392 -191
185 0.3 55 12 60 66 258 11 65 253 871 74
113 -51 4.2 -61 5.3 192 -78 41 -76 2.9 -8.2 124
-37 -68 -68 -32 -49 161 -108 148 -189 -331 -604 157

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?